Episodios

  • Ep. 84: “T Cells in Inflammation and Cancer” Featuring Dr. Jeffrey Rathmell
    Jul 30 2024
    Dr. Jeffrey Rathmell is the Cornelius Vanderbilt Professor of Immunobiology at the Vanderbilt Center for Immunobiology. His research focuses on T cell metabolism in cancer. He talks about what T cells use for fuel and his work on fatty acid synthesis. He also discusses the 'obesity paradox' in cancer immunotherapy and his favorite parts of being a scientist and professor.
    Más Menos
    1 h y 7 m
  • Ep. 83: “Biomolecular Sensors” Featuring Dr. Shana Kelley
    Jul 16 2024
    Dr. Shana Kelley is the President of the Chan Zuckerberg Biohub Chicago and the Neena B. Schwartz Professor of Chemistry and Biomedical Engineering at Northwestern University. The Kelley research group works in a variety of areas spanning bio analytical technology development and has pioneered new methods for tracking molecular and cellular analytes with unprecedented sensitivity. She talks about developing DNA-based reagentless biosensors and commercializing new technologies.
    Más Menos
    1 h y 10 m
  • Ep. 82: “Immunological Memory” Featuring Dr. Susan Kaech
    Jul 2 2024
    Dr. Susan Kaech is a Professor and Director of the NOMIS Center for Immunobiology and Microbial Pathogenesis at the Salk Institute. Her lab aims to understand how memory T cells are produced during infection and vaccination, how they function, and why they can fail to induce long-term immunity, particularly during chronic disease or cancer. In this episode, she talks about her research on T cell exhaustion and neuroimmunology, as well as her path from genetics to immunology.
    Más Menos
    1 h y 15 m
  • Ep. 81: “Respiratory Immunology” Featuring Dr. Priya Devarajan
    Jun 18 2024
    Dr. Priya Devarajan is an Assistant Professor at Stony Brook University. Her work focuses on immune memory and respiratory immunology. She talks about how aging affects the immune system and strategies to promote immune responses in the nose and lungs. She also discusses improving influenza vaccine responses and her experience interviewing for faculty positions.
    Más Menos
    1 h y 9 m
  • Ep. 80: “Engineered Biomaterials” Featuring Dr. Erika Moore
    Jun 11 2024
    Dr. Erika Moore is an Assistant Professor in the Fischell Department of Bioengineering at the University of Maryland, where her lab is committed to engineering biomaterial models that harness the regenerative potential of the immune system. She talks about building biomaterials, rejuvenating macrophages, and treating lupus. She also discusses using the right cells in research and promoting financial literacy to make science careers more accessible.
    Más Menos
    59 m
  • Ep. 79: “ILC2s, the Microbiome, and Fibroblasts” Featuring Dr. Kellen Cavagnero
    Jun 4 2024
    Dr. Kellen Cavagnero is a Postdoctoral Fellow at the University of California, San Diego. His PhD work focused on how fibroblasts — a cell type thought to be immunologically inert — contribute to chronic inflammatory conditions and defense against pathogens. He talks about staph infections, antimicrobial resistance, and the types and roles of fibroblasts. He also discusses his work in science communication, including his podcast, Inflammatory Content.
    Más Menos
    1 h y 9 m
  • IMMUNOLOGY2024™: On the Ground
    May 28 2024
    In May 2024, we attended IMMUNOLOGY2024™, the annual meeting of the American Association of Immunologists, in Chicago. We spoke with delegates about their research and impressions of the meeting, including their reasons for attending and the most memorable research presented.
    Más Menos
    35 m
  • Ep. 78: “Artificial Intelligence and Immunology” Featuring Drs. Jo Viney and Ryan Peckner
    May 21 2024
    Dr. Jo Viney is the CEO, President, & Co-Founder and Dr. Ryan Peckner is the Director of Machine Learning & Computational Biology at Seismic Therapeutic. In this special episode recorded in front of a live audience at IMMUNOLOGY2024™ in Chicago, they discuss artificial intelligence and its applications in drug discovery and protein engineering. They talk about its limitations, its role in clinical trials, and how scientists can leverage these tools to advance their careers.
    Más Menos
    1 h y 11 m